A detailed history of Geode Capital Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,218,424 shares of CRL stock, worth $241 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,218,424
Previous 1,216,793 0.13%
Holding current value
$241 Million
Previous $251 Million 4.51%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$187.96 - $245.29 $306,562 - $400,067
1,631 Added 0.13%
1,218,424 $240 Million
Q2 2024

Aug 09, 2024

BUY
$206.39 - $268.73 $6.39 Million - $8.32 Million
30,949 Added 2.61%
1,216,793 $251 Million
Q1 2024

May 13, 2024

BUY
$203.52 - $273.43 $8.11 Million - $10.9 Million
39,835 Added 3.48%
1,185,844 $321 Million
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $3.81 Million - $5.54 Million
23,186 Added 2.06%
1,146,009 $271 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $4.17 Million - $4.66 Million
21,423 Added 1.95%
1,122,823 $220 Million
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $7.16 Million - $8.2 Million
38,984 Added 3.67%
1,101,400 $232 Million
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $4.8 Million - $6.5 Million
25,019 Added 2.41%
1,062,416 $214 Million
Q4 2022

Feb 13, 2023

BUY
$197.11 - $250.07 $8.37 Million - $10.6 Million
42,486 Added 4.27%
1,037,397 $226 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $4.77 Million - $6.56 Million
26,168 Added 2.7%
994,911 $196 Million
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $2.07 Million - $3.06 Million
10,119 Added 1.06%
968,743 $207 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $8.66 Million - $12.3 Million
33,886 Added 3.66%
958,624 $272 Million
Q4 2021

Feb 11, 2022

BUY
$351.38 - $448.68 $4.77 Million - $6.1 Million
13,586 Added 1.49%
924,738 $348 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $13.1 Million - $16.1 Million
35,148 Added 4.01%
911,152 $375 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $84.1 Million - $106 Million
286,056 Added 48.49%
876,004 $323 Million
Q1 2021

May 12, 2021

BUY
$249.67 - $299.48 $6.65 Million - $7.97 Million
26,620 Added 4.73%
589,948 $171 Million
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $7.05 Million - $8.02 Million
31,759 Added 5.97%
563,328 $141 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $4.1 Million - $5.29 Million
-23,376 Reduced 4.21%
531,569 $120 Million
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $1.91 Million - $3.06 Million
16,106 Added 2.99%
554,945 $96.8 Million
Q1 2020

May 14, 2020

BUY
$98.9 - $178.34 $1.76 Million - $3.17 Million
17,751 Added 3.41%
538,839 $68 Million
Q4 2019

Feb 13, 2020

BUY
$126.05 - $152.76 $2.76 Million - $3.35 Million
21,920 Added 4.39%
521,088 $79.6 Million
Q3 2019

Nov 12, 2019

BUY
$125.07 - $143.67 $1.04 Million - $1.2 Million
8,348 Added 1.7%
499,168 $66.1 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $1.75 Million - $2.11 Million
14,176 Added 2.97%
490,820 $69.6 Million
Q1 2019

May 14, 2019

BUY
$104.82 - $146.73 $2 Million - $2.8 Million
19,115 Added 4.18%
476,644 $69.2 Million
Q4 2018

Feb 13, 2019

BUY
$105.09 - $137.23 $3.03 Million - $3.96 Million
28,878 Added 6.74%
457,529 $51.8 Million
Q3 2018

Nov 13, 2018

BUY
$112.11 - $134.54 $563,240 - $675,928
5,024 Added 1.19%
428,651 $57.7 Million
Q2 2018

Aug 14, 2018

SELL
$102.37 - $117.25 $983,059 - $1.13 Million
-9,603 Reduced 2.22%
423,627 $47.6 Million
Q1 2018

May 15, 2018

BUY
$98.19 - $115.2 $60,583 - $71,078
617 Added 0.14%
433,230 $46.2 Million
Q4 2017

Feb 13, 2018

BUY
$100.43 - $118.09 $2.86 Million - $3.36 Million
28,456 Added 7.04%
432,613 $47.3 Million
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $2.8 Million - $3.16 Million
28,908 Added 7.7%
404,157 $43.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
375,249
375,249 $38 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.